Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
Leptin and other adipokines in EAE and MS
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
Gut microbiota in early pediatric multiple sclerosis: a case-control study.
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Case Report of Lewis and Sumner Syndrome with Bilateral Vagus Nerves Paralysis for 16 Years.
Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.

Pages